to evaluate the efficacy and safety of anlotinib combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer, interventional, phase2
Record · ID 828190
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.